LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Speedy Cell Cycle Slows Stem Cell Differentiation

By LabMedica International staff writers
Posted on 28 Dec 2017
Print article
Image: A photomicrograph showing stem cells (red) and differentiating cells (green) (Photo courtesy of Cook Laboratory, University of North Carolina).
Image: A photomicrograph showing stem cells (red) and differentiating cells (green) (Photo courtesy of Cook Laboratory, University of North Carolina).
A team of cell biologists has found that the ability of pluripotent stem cells to remain in an undifferentiated state is linked to the length of time the cell spends in the G1 phase of cell division.

All dividing cells must first unwind their DNA so that it can be copied. To achieve this, cells load DNA-unwinding enzymes called helicases onto their DNA during the part of the cell cycle known as G1 phase. Cells must load enough helicase enzymes to ensure that their DNA is copied completely and in time. Stem cells divide faster than their specialized descendants, and have a much shorter G1 phase, as well. Yet these cells still manage to load enough helicases to copy their DNA. Little is known about how the amount, rate, and timing of helicase loading vary between cells that divide at different speeds.

Complete and robust human genome duplication requires loading minichromosome maintenance (MCM) helicase complexes at many DNA replication origins, an essential process termed origin licensing. Licensing is restricted to G1 phase of the cell cycle, but G1 length varies widely among cell types. Investigators at the University of North Carolina (Chapel Hill, USA) utilized single-cell flow cytometry to measure MCM loading rates in asynchronous populations of pluripotent and differentiated cells.

Results published in the November 17, 2017, online edition of the journal eLife revealed that pluripotent stem cells with naturally short G1 phases loaded MCM much faster than their isogenic differentiated counterparts with long G1 phases. During the earliest stages of differentiation toward all lineages, MCM loading slowed concurrently with G1 lengthening, revealing developmental control of MCM loading. Rapid licensing in stem cells was caused by accumulation of the MCM loading protein, Cdt1 (DNA replication factor Cdt1). Prematurely slowing MCM loading in pluripotent cells not only lengthened G1 but also accelerated differentiation. Thus, rapid origin licensing was an intrinsic characteristic of stem cells that contributed to pluripotency maintenance.

"Studies like this help explain the underlying biology of rapidly dividing cells and may inform the development of future therapies, for example stem cell therapies or cancer treatments," said study senior author Dr. Jean Cook, professor of biochemistry and biophysics at the University of North Carolina. "We suspect that rapid MCM loading is an important aspect of how cancer cells manage to grow fast without excessively damaging their DNA. It is a target worth pursuing."

Related Links:
University of North Carolina

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more